
doi: 10.1002/pbc.25278
pmid: 25307772
Kaposiform lymphangiomatosis (KLA) is a rare proliferation of abnormal lymphatic vessels often complicated by pleural/pericardial effusions and a consumptive coagulopathy that may lead to life threatening hemorrhage. Establishing the diagnosis is challenging due to the clinical heterogeneity and variable findings in laboratory values, radiographic features, and pathologic characteristics. We report three patients who had slowly progressive symptoms and presented with pleural or pericardial effusions, evidence of a consumptive coagulopathy and anemia. Despite being a rare and challenging diagnosis, KLA should be considered in patients presenting with non‐specific indolent symptoms, pleural or pericardial effusions and laboratory evidence of a consumptive coagulopathy. Pediatr Blood Cancer 2015;62:901–904. © 2014 Wiley Periodicals, Inc.
Male, Infant, Kasabach-Merritt Syndrome, Prognosis, Multimodal Imaging, Pericardial Effusion, Pleural Effusion, Child, Preschool, Hemangioendothelioma, Humans, Female, Child, Sarcoma, Kaposi
Male, Infant, Kasabach-Merritt Syndrome, Prognosis, Multimodal Imaging, Pericardial Effusion, Pleural Effusion, Child, Preschool, Hemangioendothelioma, Humans, Female, Child, Sarcoma, Kaposi
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 52 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
